Normalized administered atezolizumab dose and clinical outcomes in advanced solid tumors: an exploratory analysis of the phase I PCD4989g study

Immuno-Oncology and Technology · Elsevier

Аннотация

Publication date: December 2026 Source: Immuno-Oncology and Technology, Volume 32 Author(s): V. Moreno, M. Dorta, A. Rueda, P. Villalba, E. García-Lorenzo, M. Pedregal, B. Doger, I. Mahíllo-Fernández

Читать у издателя →

Похожие статьи